Agenus reported $456.17M in Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Agenus AGEN:US $ 456.17M 14.87M
Amgen AMGN:US $ 59294M 98M
AstraZeneca AZN:LN 96579M 3694M
Bristol Myers Squibb BMY:US $ 100357M 2677M
Celldex Therapeutics CLDX:US $ 402.96M 21.08M
Chemocentryx CCXI:US $ 419.39M 21.06M
CSL CSL:AU $ 23.44B 5.28B
Dynavax Technologies DVAX:US $ 1023M 14.02M
Eli Lilly And LLY:US $ 47063.6M 144.3M
Genocea Biosciences GNCA:US $ 38.79M 17.18M
Gilead Sciences GILD:US $ 62870M 210M
Glaxosmithkline GSK:US $ 89045M 644M
GlaxoSmithKline GSK:LN 89045M 644M
Immunogen IMGN:US $ 422.3M 59.41M
Intrexon XON:US $ 321.22M 14.34M
Jiangsu Hengrui Me. 600276:CH CH 39.82B 551.33M
Karyopharm Therapeutics KPTI:US $ 256.48M 37.56M
Macrogenics MGNX:US $ 218.04M 53.4M
Merck MRK:GR € 48717M 2482M
Northwest Biotherapeutics NWBO:US 30.66M 9.5M
Novartis NOVN:VX SF 122910M 2308M
Novavax NVAX:US $ 2622.99M 211.88M
Regeneron Pharmaceuticals REGN:US $ 27205.8M 857.1M
Sangamo Biosciences SGMO:US $ 617.13M 37.18M
Veracyte VCYT:US $ 1144.2M 29.39M
YTE INCY:US $ 5319.04M 264.81M